Your search returned 6 results.

Results
	1.	Necitumumab: a new option for first-line treatment of squamous cell lung cancer. [electronic resource] by Jiménez Aguilar, Elizabeth Zugazagoitia Fraile, Jon Paz-Ares Rodríguez, Luis Producer: 20180824 In: Expert opinion on drug metabolism & toxicology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Targeting EGFR in Lung Cancer: Current Standards and Developments. [electronic resource] by Díaz-Serrano, Asunción Gella, Pablo Jiménez, Elisabeth Zugazagoitia, Jon Paz-Ares Rodríguez, Luis Producer: 20190312 In: Drugs vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study. [electronic resource] by Thatcher, Nicholas Goldschmidt, Jerome H Thomas, Michael Schenker, Michael Pan, Zhiying Paz-Ares Rodriguez, Luis Breder, Valery Ostoros, Gyula Hanes, Vladimir Producer: 20200511 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients. [electronic resource] by Carrato, Alfredo Paz-Ares Rodríguez, Luis Rodríguez Lescure, Alvaro Casas Fernández de Tejerina, Ana M Díaz Rubio García, Eduardo Pérez Segura, Pedro Constenla Figueiras, Manuel García Carbonero, Rocío Gómez Codina, José Lluch Hernández, Ana Maroto Rey, José Pablo Martín Jiménez, Miguel Mayordomo Cámara, José Ignacio Moreno Nogueira, José Andrés Rueda Domínguez, Antonio Producer: 20091223 In: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial. [electronic resource] by Huber, Rudolf M Hansen, Karin H Paz-Ares Rodríguez, Luis West, Howard L Reckamp, Karen L Leighl, Natasha B Tiseo, Marcello Smit, Egbert F Kim, Dong-Wan Gettinger, Scott N Hochmair, Maximilian J Kim, Sang-We Langer, Corey J Ahn, Myung-Ju Kim, Edward S Kerstein, David Groen, Harry J M Camidge, D Ross Producer: 20210106 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. [electronic resource] by Kim, Dong-Wan Tiseo, Marcello Ahn, Myung-Ju Reckamp, Karen L Hansen, Karin Holmskov Kim, Sang-We Huber, Rudolf M West, Howard L Groen, Harry J M Hochmair, Maximilian J Leighl, Natasha B Gettinger, Scott N Langer, Corey J Paz-Ares Rodríguez, Luis G Smit, Egbert F Kim, Edward S Reichmann, William Haluska, Frank G Kerstein, David Camidge, D Ross Producer: 20170908 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)